Gujarat Exclusive > National-World > COVID cases in India cross 1 crore mark

COVID cases in India cross 1 crore mark


India on Saturday crossed over one crore COVID cases in the country, next to the US which crossed the mark last month. 25,152 fresh infections were reported in the last 24 hours taking the tally to 1,00,04,599. Government data said 347 deaths were recorded in the country during the same time taking the fatalities to 1,45,136.

India has a recovery rate of 95%, one of the highest globally. It took India 325 days to cross the 1 crore cases.

“Recoveries are more than 30 times the active cases (currently only 3.14% of total cases),” the Union Health Ministry said this morning.

Recoveries touched 95 lakh in December from a mere 50,000 in May, the ministry said in a tweet.

“Central government’s calibrated strategies through a ‘Whole of Government’ approach have sharply focussed on high recovery rate and low fatality rate on a sustained basis,” the Health Ministry said in one of the tweets.

Other COVID statistics

  • Across India, over 16 crore COVID tests have been conducted so far.
  • The death rate was at 1.45%, while the positivity rate was 2.14%.
  • With 18.88 lakh cases, Maharashtra has logged the highest number of cases in the country.
  • The other states with the highest cases include Karnataka (9.07 lakh), Andhra Pradesh (8.77 lakh), Tamil Nadu (8.04 lakh), Kerala (6.93 lakh), and Delhi (6.14 lakh).

Status of COVID vaccines

The government on Wednesday said Covid vaccines will be voluntary and said India-made vaccines will be as effective as any vaccine developed by other countries.

Six vaccines, including one by Hyderabad-based Bharat Biotech and Pune-based Serum Institute of India, are undergoing clinical trials in India.

Also Read: Congress’ Sonia Gandhi meets rebels, other leaders to help sort out party issues

India has enough capacity to produce COVID-19 vaccines for its needs and also export them to other countries that need its help, Finance Minister Nirmala Sitharaman said on Friday.

The United States on Friday cleared the Moderna vaccine for emergency use.

Three vaccine makers – Pfizer, Bharat Biotech, and Serum Institute of India – have sought emergency approval from the drug controller in India.




To read the latest news in Gujarati click here